Panakeia ("the Company"), the world's first in silico multi-omics company, today unveiled landmark pathway activation data in cancers at the American Association for Cancer Research (AACR) Annual ...
The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...
Bismuth-doped gallium nanoparticles transform into cell-puncturing spikes under freezing, killing drug-resistant lung, ...
Therapeutic fasting offers a metabolic approach to chronic pain by shifting to fat metabolism, reducing systemic inflammation ...
Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced preclinical data highlighting an ...
NIQ (NYSE: NIQ), a leading consumer intelligence company, and Stirista, a provider of identity-driven marketing solutions, ...
Systemic lupus erythematosus (SLE) involves ongoing inflammation, tissue damage from immune complexes, and incomplete immune resolution. A key factor ...
Olverembatinib, an investigational multikinase inhibitor (approved in China for CML), inhibits Src-family kinases (e.g., Lyn, ...
Attention is a physical experience, and the channels that respect that reality will always command deeper engagement.
When an axolotl loses a limb to a hungry predator, it sprouts a structurally sound replacement, rebuilding flesh, bone, and ...
If your immune system overreacts to pollen or other allergens, a diet rich in compounds that boost immune health and reduce ...
Indonesian cosmetics group Wardah has appointed Al Qubaisi as its global ambassador, for its “Own Your Finish” campaign ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results